Stereotactic ablative body radiotherapy for primary kidney cancer: what have we learned from prospective trials and what does the future hold?

Future Oncol. 2016 Mar;12(5):601-6. doi: 10.2217/fon.16.6. Epub 2016 Feb 3.

Shankar Siva^{1

2}, Christopher P Daniels¹, Rodney J Ellis³, Lee Ponsky⁴, Simon S Lo³

¹ Division of Radiation Oncology & Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne 3002, Australia.
² Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville 8006, Australia.
³ Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.
⁴ Department of Urology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA.

No abstract available

Keywords: SBRT; clinical trials; radiosurgery; renal cell carcinoma.

Publication types